AIM Earnings

Quarterly EPS
$-6.41
Q3 2024
$-0.03
Q4 2024
$-0.05
Q1 2025
$-3.68
Q2 2025
$-1.57
Q3 2025
$0.00
Q4 2025
$-0.69
Q1 2026
$-0.43
Q2 2026
Latest Revenue26.0K
Latest Net Income-3788000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.4326.0K-3788000+4.0%+88.3%
Q1 2026-$0.6922.0K-3023000+37.5%-1,280.0%
Q4 202521.0K-4175000-53.3%
Q3 2025-$1.5726.0K-3284000-25.7%+75.5%
Q2 2025-$3.6825.0K-2794000-50.0%-6.1%
Q1 2025-$0.0516.0K-3705000-60.0%+58.3%
Q4 2024-$0.0345.0K-5967000-30.8%+88.5%
Q3 2024-$6.4135.0K-3700000-23.9%-3,906.3%
Q2 2024-$3.4750.0K-1836000
Q1 2024-$0.1240.0K-5817000
Q4 2023-$0.2665.0K-12576000
Q3 2023-$0.1646.0K-7816000
AIM ImmunoTech (AIM) — Earnings